Titiun Yejiel’s Tenax Therapeutics TENX Stock Holding History

Titiun Yejiel’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16	Hold	1	–	–	﹤0.01%	57
2025 Q4	$12	Buy	+1	New	+$9	﹤0.01%	58

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Titiun Yejiel's TENX Position: Q1 2026 in Review

Titiun Yejiel held its Tenax Therapeutics (TENX) position steady in Q1 2026 at 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #57.

Titiun Yejiel first reported a position in TENX in Q4 2025 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Titiun Yejiel held 1 share of Tenax Therapeutics worth $16 as of Q1 2026.
Titiun Yejiel left its Tenax Therapeutics share count unchanged in Q1 2026.
Tenax Therapeutics made up ﹤0.01% of Titiun Yejiel's portfolio in Q1 2026, its #57 holding.
Titiun Yejiel first reported a position in Tenax Therapeutics in Q4 2025 and has held it in 2 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Titiun Yejiel's 13F filing for Q1 2026, filed 4 May 2026.